Featured Articles

Diagnosis and Management of Primary Hyperhidrosis: Practical Guidance and Current Therapy Update

By July 27, 2020No Comments

Skin of Color Update

Featured Article

With the busy practitioner and dermatology resident in mind, we provide here a disease state primer for hyperhidrosis, a top-line review of the breadth of literature underscoring the overall burden of the disease, a practical guide to differential diagnosis, and an update on current treatment approaches, including for the most common form of the condition, primary axillary hyperhidrosis.

Read more

A case study on the importance of early and effective management strategies for those suffering with hyperhidrosis.

Joe Gorelick MSN FNP-C, Adam Friedman MD

In the most simplistic definition, hyperhidrosis is excessive sweating. However, it is largely misunderstood, often goes undiagnosed, and continues to be inadequately managed for many patients. Approximately half of those who self-identify as having excessive sweating do not discuss their symptoms with healthcare professionals despite the severe negative impact on their quality of life; reasons for this include the misconception that hyperhidrosis is not a medical condition and that no treatments exist.

In one study, only half of patients who reported their symptoms to a healthcare professional were ultimately diagnosed with primary hyperhidrosis, which may reflect a reality of widespread underdiagnosis of the condition.1 In a survey conducted by the International Hyperhidrosis Society (IHhS), 48.9% of patients waited 10 or more years before seeking medical help for their excessive sweating.2

With the busy practitioner and dermatology resident in mind, here we provide a disease state primer for hyperhidrosis, a top-line review of the breadth of literature underscoring the overall burden of the disease, a practical guide to differential diagnosis, and an update on current treatment approaches.3, 4 In addition, a case study in primary axillary (underarm) hyperhidrosis is presented to provide a real-life perspective from the clinic on the importance of early and effective management strategies for those suffering with hyperhidrosis.

Read Article Now
Article Cited in this Post

You May Also Like

Journal of Drugs in Dermatology JDD Article About Top Chief Complaints and Diagnoses for Outpatient Dermatology Patients of Color

Top Chief Complaints and Diagnoses for Outpatient Dermatology Patients of Color

| Featured Articles, Latest News, Skin of Color, The Latest | No Comments
Did you miss it? By 2044, people with skin of color (SOC) will make up the majority of the U.S. population—but dermatology still lags behind in addressing their unique needs.…
Journal of Drugs in Dermatology JDD Article About Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%

Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%

| Acne, Featured Articles, Latest News, The Latest | No Comments
Acne Treatment Without the Dry-Out: Clascoterone Cream 1% Proves Gentle on the Skin Barrier Topical acne meds often come with an unfortunate side effect: dry, irritated skin that leaves patients…
Journal of Drugs in Dermatology JDD Article About The State of the Clinical Management Union: A Cross-Sectional Survey of Persons With Hidradenitis Suppurativa

The State of the Clinical Management Union: A Cross-Sectional Survey of Persons With Hidradenitis Suppurativa

| Acne, Featured Articles, Latest News, The Latest | No Comments
April Issue Must-Read! Hidradenitis suppurativa (HS) isn’t just painful—it’s deeply isolating. And new data reveals why: the majority of people living with HS don’t feel heard, treated, or informed. In a…

Leave a Reply